About Medeloop
Medeloop is an AI-powered clinical research platform designed to streamline and accelerate the medical evidence generation process for physicians and healthcare teams. The company aims to empower clinical researchers with AI tools to conduct their work more efficiently, thoroughly, and productively. Medeloop offers an “operating system for clinical research” that covers the entire research lifecycle, from identifying grant opportunities and securing funding to generating real-world evidence from patient data and delivering actionable insights at the point of care.
The platform provides a comprehensive suite of AI-powered products, including Analytics for real-world evidence generation, EvidenceKit for accessing all-payer claims data, Grants for AI-assisted grant discovery and proposal writing, and Care for population health management and patient intelligence. Medeloop’s core offering, Medeloop Analytics, utilizes autonomous AI research agents to ingest, aggregate, and harmonize diverse, multimodal data from electronic health records (EHRs), wearables, multi-omics, and institution-level datasets, creating a knowledge graph. This allows for rapid data analysis and the generation of publication-ready evidence in minutes. The platform is built to work with various data sources, including EHRs, claims datasets, disease registries, labs, and custom institutional databases, without requiring OMOP mapping or CDM conversion. It also features a semantic code engine that automatically maps research concepts to major coding systems like ICD-10, CPT, NDC, and SNOMED.
Medeloop’s solutions are trusted by leading institutions such as Stanford Medicine, Duke, Hartford Healthcare, Cedars-Sinai, NYU, and UC San Diego, processing data from over 180 million real-world patient records. The company emphasizes a “human-in-the-loop” approach with full audit trails, editable research plans, and transparent AI reasoning, ensuring validation at every step from clinical code selection to statistical output. Medeloop is particularly focused on accelerating breakthroughs in rare disease research, an area often challenged by small patient populations and fragmented data.
Focus Areas
Business Intelligence
| Key Investors | Inovia Capital, Icon Ventures, General Catalyst, Maven Ventures, Healthier Capital, Up2 Opportunity Fund, CFO Advisors, OVO Fund, NV investments, Kenneth C. Frazier, Linda S. Grais |
| Partnerships | HealthVerity, Mila - Quebec AI Institute, McGill University, University of California San Diego (UCSD), University of California San Francisco (UCSF), Stanford Medicine, Duke, Hartford Healthcare, Cedars-Sinai, NYU |
| Acquisitions | unknown |
| Technology | Cloud-native infrastructure, federated execution (compute goes to data), data-agnostic architecture, semantic code engine (maps to ICD-10, CPT, NDC, SNOMED), NLP models (OpenAI, LangChain, Ragflow), AI modules for visual/graphical datasets, end-to-end encryption, multi-factor authentication, role-based access controls, PostgreSQL, Python, ReactJS, NodeJS, Redis, Elastic Search |
| FDA Clearances | unknown cleared products (estimated) |
What Physicians Need to Know
Medeloop empowers physicians by offering an intuitive, no-code platform that transforms complex research questions into publication-ready results in minutes, not months. [3, 14, 17] It provides AI-generated clinical summaries and interactive patient timelines, surfacing insights at the point of decision within existing clinical workflows. [2] The platform's ability to quickly analyze real-world data, identify high-risk patients, and streamline grant applications and research publication can significantly reduce administrative burden and accelerate the translation of research into improved patient care. [2, 3, 13, 17]
Medeloop's platform is designed for seamless integration with existing healthcare infrastructure. It supports EHRs, claims datasets, disease registries, labs, and institutional databases, including custom schemas. [9] The platform uses a federated execution model, meaning compute goes to the data, and data never leaves the client's secure environment (AWS, Azure, GCP, or on-prem). [3, 8, 9] Medeloop has also partnered with HealthVerity to provide access to over 200 million de-identified patient records for enhanced real-world data analysis. [10, 14]
What the Web Says
Medeloop is an AI-powered platform designed for clinical research and healthcare, offering tools for data analysis, study management, and care delivery. The platform aims to streamline research by automating tasks, working with various data sources, and ensuring data security through federated execution. While product reviews are limited on major platforms like G2 and Capterra, employer reviews on Indeed suggest a mixed experience for employees.
Overall: MixedStrengths
- AI-powered tools for clinical research, grant writing, and care management.
- Federated execution ensures data security by processing data within the user's infrastructure.
- Compatible with various healthcare data sources (EHRs, claims, registries) and data models.
- Validated outputs with built-in checks and continuous benchmarking.
- No coding required for research questions, with options for technical teams to customize.
- Offers solutions for pharmaceutical companies, healthcare organizations, and researchers.
Limitations
- Limited public product reviews available on major platforms.
- Mixed employee reviews regarding work-life balance, pay, and management.
- Some employees reported a lack of training and support, particularly for entry-level positions.
- Concerns about miscommunication within management.
- Reports of a stressful work environment and lack of appreciation.
- One review mentioned issues with PTO and insufficient raises.
Based on reviews from: Indeed.com, Medeloop.com, ReviewAI.net, Reddit.com, Capterra.com
Last updated: 2026-08-24
Videos
News, demos, and interviews about Medeloop.
Videos load interactively. If none appear, search YouTube for Medeloop →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Medeloop.
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]